At least three genes account for familial papillary thyroid carcinoma: TCO and MNG1 excluded as susceptibility loci from a large Tasmanian family

European Journal of Endocrinology

Volumn 141, Issue 2, 1999, Pages 122-125

  McKay, J D ^c   Williamson, J ^c   Lesueur, F ^a   Stark, M ^a   Duffield, A ^c   Canzian, F ^a   Romeo, G ^a   Hoffman, L ^b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b ROYAL HOBART HOSPITAL   (Australia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN MNG1; PROTEIN TCO; UNCLASSIFIED DRUG;

ARTICLE; AUSTRALIA; AUTOSOMAL DOMINANT INHERITANCE; CANCER SUSCEPTIBILITY; FAMILIAL CANCER; GENE LOCUS; GENE MAPPING; GENETIC LINKAGE; HUMAN; NODULAR GOITER; PEDIGREE ANALYSIS; PRIORITY JOURNAL; THYROID PAPILLARY CARCINOMA;

CARCINOMA, PAPILLARY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); MALE; MICROSATELLITE REPEATS; PEDIGREE; TASMANIA; THYROID NEOPLASMS;

EID: 0032807460     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1410122     Document Type: Article

References (29)

1. Farid NR, Shi Y & Zou M. Molecular basis of thyroid cancer. Endocrinology Review 1994 15 202-232.
2. Stoffer SS, Van Dyke DL, Vaden Bach J, Szpunar W & Weiss L. Familial papillary carcinoma of the thyroid. American Journal of Medical Genetics 1986 25 775-782.
3. Hrafnkelsson J, Tulinius H, Jonasson JG, Olafsdoittir G & Sigvaldason H. Papillary thyroid carcinoma in Iceland: a study of the occurrence of families and the coexistence of other primary tumours. Acta Oncology 1989 28 785-788.
4. Kwok CG & McDougall IR. Familial differentiated carcinoma of the thyroid: report of five pairs of siblings. Thyroid 1995 5 395-397.
5. Galanti MR, Ekbom A & Yuen J. Parental cancer and risk of papillary and follicular thyroid carcinoma. British Journal of Cancer 1997 75 451-456.
6. Austoni M. Thyroid papillary carcinoma in identical twins. The Lancet 1998 14 1115.
7. Kraimps JL, Bouin-Pineau MH, Amati P, Mothes D, Bonneau D, Marechaud R & Barbier J. Familial papillary carcinoma of the thyroid. Surgery 1997 121 715-718.
8. Lote K, Andersen K, Nordal E & Brennhovd IO. Familial occurrence of papillary thyroid carcinoma. Cancer 1980 46 1291-1297.
9. Grossman RF, Tu SH, Duh QY, Siperstein AE, Novosolov F & Clark OH. Familial nonmedullary thyroid cancer. Archives of Surgery 1995 130 892-899.
10. Burgess JR, Duffield A, Wilkinson SJ, Ware R, Greenaway TM, Percival J & Huffman L. Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid. Journal of Clinical Endocrinology and Metabolism 1997 82 345-348.
11. Bignell GR, Canzian F, Shayegi M, Stark M, Shuggart YY, Biggs P et al. Familial non toxic multinodular goitre locus maps to chromosome 14q but does not account for familial non medullary thyroid cancer. American Journal of Human Genetics 1997 61 1123-1130.
12. Canzian F, Amati P, Harach HR, Kraimps JL, Lesueur F, Barbier J et al. A gene predisposing to familial thyroid tumours with cell oxyphilia maps to chromosome 19p13.2. American Journal of Human Genetics 1998 63 1743-1748.
13. Grieco M, Santoro M, Berlingieri MT, Donghi R, Pierotti MA, Della Porta G et al. Molecular cloning of PTC, a new oncogene found activated in human thyroid papillary carcinomas and lymph node metastasis. Annals of the New York Academy of Sciences 1988 551 380-381.
14. Bongarzone I, Butti MG, Coronelli S, Borrello MG, Santoro M, Mondellini P et al. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Research 1994 54 2979-2985.
15. Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, Grieco M et al. Molecular characterisation of RET/PTC3; a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene 1994 9 509-516.
16. Bongarzone I, Pierotti MA, Monzini N, Mondellini P, Manenti G, Donghi R et al. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene 1989 4 1457-1462.
17. Martin-Zanca D, Hughes SH & Barbacid M. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 1986 319 743-748.
18. Di Renzo MF, Olivero M, Ferro S, Prat M, Bongarzone I, Pilotti S et al. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 1992 7 2549-2453.
19. Cetta F, Chiappetta G, Marine Melillo R, Petracci, M, Mantalto G, Santoro M et al. The ret/ptc1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas. Journal of Clinical Endocrinology and Metabolism 1998 83 1003-1006.
20. Harach HR, Williams GT & Williams ED. Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular neoplasm. Histopathology 1994 25 549-561.
21. Lynch FD, Ostermeyer EA, Lee MK, Fernando Arena J, Ji H, Dann J et al. Inherited mutations in PTEN that are associated with breast cancer, Cowden's disease and juvenile polyposis. American Journal of Human Genetics 1997 61 1257-1260.
22. Russo D, Tumino S, Arturi F, Vigneri P, Grasso G, Pontecorvi A et al. Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning insular carcinoma. Journal of Clinical Endocrinology and Metabolism 1997 82 735-738.
23. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993 365 649-651.
24. Gyapay G, Morissette J, Vignal A, Dib C, Fizomes C, Millasseau P et al. The 1993-94 Genethon human genetic linkage map. Nature Genetics 1994 13 246-249.
25. Lathrop GM & Lalouel JM. Easy calculation of lod scores and genetic risk on small computers. American Journal of Human Genetics 1984 36 460-465.
26. O'Connell JR & Weeks DE. The VITESSE algorithm for rapid exact multilocus linkage analysis via genotype set-recoding and fuzzy inheritance. Nature Genetics 1995 11 402-408.
27. Goldgar DE, Easton DF, Cannon-Albright LA & Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. Journal of the National Cancer Institute 1994 86 1600-1608.
28. Mulligan LM, Kwok, JB, Healey C, Elsdon MJ, Eng C, Gardner E et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993 363 458-460.
29. Decker RA. Expression of papillary thyroid carcinoma in multiple endocrine neoplasia type 2A. Surgery 1993 114 1053-1063.